Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health

Here's a great way to earn strong market returns over the long term: Identify companies that have been ignored or underestimated by most investors but have attractive prospects; buy their shares at a deep discount; and hold on to them for a long time. Picking out such corporations isn't easy, though.Let's consider two potential candidates: Iovance Biotherapeutics (NASDAQ: IOVA) and Teladoc Health (NYSE: TDOC). These two healthcare specialists have faced significant challenges in recent years but are trying to mount a comeback. Which one of the two is the more attractive contrarian buy? Let's find out.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool